Trade ZBIO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Zenas BioPharma, Inc. (ZBIO) is trading at US$27.26, up 3.89% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$2.1B. Over the past 52 weeks, ZBIO has traded between US$13.50 and US$44.60. On Syfe you can trade ZBIO with $0 commission and add it to your watchlist.
| Previous close | US$26.24 |
|---|---|
| Market cap | US$2.1B |
| 52-week range | US$13.50 – US$44.60 |
| Volume | 429.6K |
| Exchange | US |
Zenas BioPharma, Inc.
Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.
Year: 2024
--Earnings Flash (ZBIO) Zenas BioPharma Posts Q2 Loss $1.77 a Share, vs. FactSet Est of $1.12 Loss
Aug 13, 11:12 AM · MT Newswires
-- Earnings Flash (ZBIO) Zenas BioPharma, Inc. Reports Q2 Revenue $1.0M
Aug 13, 11:01 AM · MT Newswires
Zenas BioPharma Bear Case Overlooks Obexelimab's Commercial Potential, Wedbush Says
Jul 17, 12:13 PM · MT Newswires
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Wednesday Amid Fresh Economic Signals
Jun 3, 1:10 PM · MT Newswires
Zenas BioPharma, Inc. (ZBIO) stock is trading at US$27.26, +3.89% from the previous close of US$26.24.
The market cap for Zenas BioPharma, Inc. (ZBIO) stock is approximately US$2.1B.
The 52-week high for Zenas BioPharma, Inc. (ZBIO) stock is US$44.60.
The 52-week low for Zenas BioPharma, Inc. (ZBIO) stock is US$13.50.
Zenas BioPharma, Inc. (ZBIO) does not currently pay a dividend.
Stay on top of ZBIO
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
